Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

Amgen · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
relapsed multiple myeloma, refractory multiple myeloma, carfilzomib, dexamethasone, daratumumab, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 865853
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.